IVF Clinic Success Rates vs. Cost: How SART Data, Prior Auth Traps, and a $12K Quote Gap Hide Which Clinic Will Actually Get You to Live Birth
Two Clinics, Same Quote, Completely Different Outcomes
You've done the consult at two clinics. Clinic A quotes $14,500 per cycle. Clinic B quotes $16,200. Both show roughly 55% "success rates" on their websites. Clinic A is 20 minutes closer. You're about to pick Clinic A on price and convenience.
Before you do — those numbers don't mean what you think they mean. And the gap between a good decision and a costly one here isn't $1,700. It's closer to $35,000 and an extra year of your life.
This post is about how to actually decode IVF clinic success rates using SART data, why prior authorization delays are silently destroying cycle outcomes for thousands of patients, and how the real cost spread between clinics — once you account for everything — routinely exceeds $12,000 per cycle before you've even talked about what happens if it fails.
The Prior Auth Problem Is Not Just a Medicare Issue — It's Your IVF Cycle
KFF Health News recently reported on the death of Eric Tennant after his insurer, West Virginia's Public Employees Insurance Agency, denied the cancer treatment his doctor had recommended — through prior authorization delays. His widow's advocacy pushed West Virginia's governor to sign patient protection legislation in March 2026.
Fertility patients don't usually face a life-or-death emergency from a prior auth denial. But they face something that compounds in its own brutal way: a delayed cycle is a lost cycle, and at 38, you don't get that month back.
Here's how this plays out in IVF specifically. Insurance plans that cover fertility treatment — and based on Feralyx's analysis of our state_fertility_mandates dataset covering all 51 jurisdictions, only 21 states mandate any fertility coverage at all — often require prior authorization for each IVF cycle. That process can take 2–6 weeks. It frequently requires documented failure of less-expensive treatments first (IUI, medicated cycles). And it can be denied mid-process, after you've already started medications.
Our ivf_costs dataset (600 rows sourced from FertilityIQ) shows that medication costs alone average $4,200–$6,800 per retrieval cycle depending on protocol and pharmacy. If your prior auth gets denied after day 3 of stimulation, that $5,000 in injectables doesn't come back. The cycle cancellation rate at clinics with aggressive insurance-dependent patient populations is meaningfully higher — and that cancellation rate never shows up in the SART success data you're comparing.
If you're navigating whether your state's mandate or employer plan covers IVF, the full breakdown of state fertility mandates, ERISA loopholes, and what you'll actually pay is here.
How Clinics Cherry-Pick Statistics (And Why It Looks Exactly Like the Medicare Advantage Upcoding Problem)
Healthcare Dive's recent reporting on bipartisan senators pressuring CMS to crack down on Medicare Advantage overpayments illustrates a dynamic that maps almost perfectly onto IVF clinic statistics: when financial incentives reward favorable-looking numbers, the numbers get managed.
In Medicare Advantage, insurers submit diagnosis codes that make their patient populations look sicker — triggering higher risk-adjusted payments. The practice is called upcoding. CMS estimates it costs taxpayers billions annually.
In IVF, the equivalent is patient selection bias. Clinics that want high SART success rates have a simple tool available to them: they can decline to treat patients with poor prognoses. Patients with diminished ovarian reserve (low AMH — anti-Müllerian hormone, a blood marker of egg supply), advanced maternal age, or complex diagnoses like recurrent implantation failure represent statistical risk. Turning them away, or pushing them toward donor egg cycles where success rates are dramatically higher, inflates the clinic's published numbers.
SART does publish cycle-level data, and our cdc_art_ivf_success_rates dataset — 2,880 rows drawn from CDC ART reporting — captures meaningful variation. But here's what most patients don't realize: SART reports success rates by age bracket, not by diagnosis. So a clinic that treats mostly 32-year-olds with no diagnosis will publish numbers that look dramatically better than a clinic that specializes in recurrent pregnancy loss or poor responders — even if that second clinic is objectively delivering better outcomes for the patients it serves.
The metric you actually want to compare is live birth rate per retrieval for patients with your age and diagnosis profile. That's nearly impossible to extract from SART's published reports without significant data work.
This is the kind of analysis Feralyx runs for you — matching your age, AMH, AFC (antral follicle count — the ultrasound measure of visible follicles), and diagnosis against clinic-level CDC ART data so you're comparing the right cohort, not the clinic's most flattering headline number.
What SART Success Rates Are Actually Telling You (And What They're Not)
Let's work through a real example. You're 37. You're looking at two clinics:
| Metric | Clinic A | Clinic B |
|---|---|---|
| Quoted cycle cost | $14,500 | $16,200 |
| SART live birth rate (all ages) | 54% | 51% |
| SART live birth rate (35–37) | 44% | 47% |
| Cancellation rate (poor response) | 18% | 9% |
| Average embryos per retrieval | 2.1 | 3.4 |
| PGT-A (embryo genetic testing) offered | Add-on | Bundled protocol |
| FET (frozen embryo transfer) included | No | Yes |
Clinic A looks cheaper and shows a higher overall success rate. But for a 37-year-old — your actual cohort — Clinic B's age-matched live birth rate is 3 points higher. Clinic B's cancellation rate is half that of Clinic A's, which means fewer cycles that cost you $5,000+ in medications without producing any embryos. Clinic B's higher average embryo yield means more chances per retrieval. And Clinic B has PGT-A (preimplantation genetic testing for chromosomal abnormalities — the screening that identifies which embryos are most likely to result in a healthy birth) bundled into its protocol rather than added at $3,000–$5,000 separately.
Now run the real cost comparison:
Clinic A (1 retrieval + 1 FET attempt):
- Base cycle: $14,500
- Medications: $5,200 (average from Feralyx medication_costs dataset, 240 rows)
- Monitoring: $1,800
- PGT-A (5 embryos tested): $4,500
- FET: $3,800
- Total: $29,800
Clinic B (1 retrieval + 1 FET attempt):
- Base cycle (includes FET + PGT-A): $16,200
- Medications: $5,200
- Monitoring: $1,200 (included monitoring visits)
- Total: $22,600
The "cheaper" clinic costs you $7,200 more for the same attempt. And that's before factoring in the 18% vs. 9% cancellation rate difference — meaning at Clinic A, roughly 1 in 5 cycles ends with a bill and no embryos.
For a deeper look at how the $14K–$15K clinic quote reliably becomes $28K–$35K after all line items, this full IVF cost breakdown for 2026 walks through every component.
The Cumulative Probability Math That Changes Everything
Single-cycle success rates are almost the wrong number to compare. What you actually need is cumulative live birth probability across the number of cycles you're realistically willing and able to attempt.
Feralyx's cdc_art_ivf_success_rates dataset lets us model this. For a 37-year-old with a 44% per-cycle live birth rate (Clinic A's age-matched figure):
- After 1 cycle: 44% cumulative chance
- After 2 cycles: 1 - (1 - 0.44) x (1 - 0.44) = 69%
- After 3 cycles: 1 - (0.56)³ = 82%
Now run the same calculation for Clinic B at 47%:
- After 1 cycle: 47%
- After 2 cycles: 1 - (0.53) x (0.53) = 72%
- After 3 cycles: 1 - (0.53)³ = 85%
Three percentage points per cycle compounds into a meaningful gap in cumulative odds — and a meaningful gap in the expected number of cycles you'll need. Across 2–3 cycles at $22,600 each (Clinic B) vs. $29,800 each (Clinic A), the total cost differential reaches $21,600 for the same probability of live birth.
You can model this for your specific age, clinic pair, and number of planned cycles at Feralyx.
What Financing Doesn't Fix (And What to Ask Before Signing)
Some patients, when confronting a $30,000+ total cost, turn to specialty fertility financing cards or medical credit products. These can serve a real function — but as NerdWallet's recent analysis of alternative medical credit products notes, specialty financing often comes with significant annual fees, unusual qualification criteria, and deferred interest structures that transform a $10,000 draw into a $14,000 obligation if the promotional period lapses.
Financing solves a cash flow problem. It does not solve a clinic selection problem. If you're taking on debt to fund IVF cycles, which clinic you choose matters even more — because you're financing not just the first cycle, but the statistical likelihood of needing a second or third.
The complete breakdown of IVF financing structures — shared-risk programs, pay-per-cycle, and personal loans — with break-even math is in this IVF financing comparison.
The Four Numbers to Demand From Any Clinic Before Your Next Cycle
Before you commit to another cycle — at your current clinic or a new one — get these four numbers in writing:
- Age-matched live birth rate per retrieval for your age bracket and primary diagnosis (not their overall SART rate)
- Cancellation rate — what percentage of stimulation cycles are cancelled before retrieval due to poor response or other complications
- Average number of usable (euploid, or chromosomally normal) embryos per retrieval for patients in your age and AMH range
- All-in cost estimate including medications, monitoring, PGT-A if recommended, and FET — not the base cycle fee
If a clinic won't give you numbers 1 and 2 specifically for your cohort, that tells you something. Clinics with strong outcomes for patients like you aren't hiding those numbers.
For a full walkthrough of how SART data breaks down by age bracket — including what the 35, 38, and 41 cohorts look like and how to calculate cumulative success for your situation — see IVF live birth rates at 35, 38, and 41: how to read SART clinic data before committing to a $25K cycle.
Before You Schedule That Consult
The fertility industry's information asymmetry is real and it costs patients money — often $20,000–$40,000 worth of it across multiple cycles at the wrong clinic. Insurance prior authorization battles delay treatment, cancelled cycles waste medication costs, and cherry-picked statistics make genuinely inferior clinics look identical to excellent ones on a website comparison.
Feralyx was built specifically to close that gap — pulling from 10,467 data points across CDC ART success rate data, FertilityIQ cost benchmarks, and state mandate coverage maps to show you what your specific profile looks like at specific clinics, before you spend another dollar.
Compare clinics with your actual age, diagnosis, and budget at Feralyx.
The spreadsheet you've been trying to build in your head? We built it for you.
Sources
- After Man’s Death Following Insurance Denials, West Virginia Tackles Prior Authorization — KFF Reproductive Health
- Readers Sound Off on Wage Garnishment, Work Requirements, and More — KFF Reproductive Health
- Bipartisan lawmakers urge CMS to crack down on Medicare Advantage overpayments — Healthcare Dive
- Elevance sidesteps Medicare Advantage sanctions for now — Healthcare Dive
- 5 Things to Know About the Karta Card — NerdWallet Health